Advertisement Aldagen secures $18.4 million in financing - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Aldagen secures $18.4 million in financing

US based biotechnology company Aldagen has raised $18.4 million in a private round of financing.

The financing was obtained from existing investors, including Intersouth Partners, Tullis-Dickerson, Harbert Venture Partners and the Aurora Funds.

The company plans to use the proceeds raised in this financing to further advance the development of its four clinical-stage product candidates and for general corporate purposes.